Reiter’s Syndrome Following Intravesical Bacillus Calmette- ‑Guérin Immunotherapy for Bladder Carcinoma in situ
Intravesical Bacillus Calmette-Guérin (BCG) immunotherapy after transurethral resection of non-muscle-invasive bladder cancer has been proven to reduce the recurrence and progression of the disease. Unfortunately, the treatment is associated with adverse effects that can induce other chronic heal...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
2026-01-01
|
| Seri Bilgileri: | Acta Clinica Croatica |
| Konular: | |
| Online Erişim: | https://hrcak.srce.hr/file/501877 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|